Centro Medico Teknon-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study

    British Journal of Haematology